🏛️ Verified NIH Record • Updated 2024-10-10
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment (NCT03732794)
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: AtriCure, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to evaluate the safety and effectiveness of the AtriCure CryoICE system in performing the Cox-Maze III lesion set, in conjunction with Left Atrial Appendage (LAA) exclusion using the AtriClip device.
Who can join: Review the eligibility criteria below.
Location: UCLA Medical Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- UCLA Medical Center — Los Angeles, California
- Washington Adventist Hospital — Washington D.C., District of Columbia
- Northwestern Medicine — Chicago, Illinois
- Franciscan Health — Indianapolis, Indiana
- Deaconess Gateway Hospital — Newburgh, Indiana
- University Of Maryland — Baltimore, Maryland
- University of Michigan — Ann Arbor, Michigan
- Mayo Clinic — Rochester, Minnesota
- St. Luke's Hospital — Kansas City, Missouri
- Mount Sinai Icahn School of Medicine — New York, New York
- NYP-Weill Cornell — New York, New York
- Northwell Health Systems — New York, New York
- St. Joseph Hospital Health Center — Syracuse, New York
- St Thomas West Hospital — Nashville, Tennessee
- West Virginia University — Morgantown, West Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atrial Fibrillation (AF)
- Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring — La Jolla, California
- Phase-Aligned Atrial Fibrillation Mapping — Cleveland, Ohio
- Left Atrial Pressure-Guided Heart Failure Optimization During Atrial Fibrillation Ablation (LAP AF-HF) — Milwaukee, Wisconsin
- P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation — Paramus, New Jersey
- Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation — Huntsville, Alabama
Explore by condition: All Atrial Fibrillation (AF) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.